Elicera Therapeutics AB (publ)

kr 2.60As of Sun 8 Nov 2026, 12:00 UTC
STO:ELICHealthcare
Country Sweden
PE (Fwd) •••
TSR 5Y CAGR (9.92%)
Div yield —
ROE (41.69%)
Biotechnology
Beta (5Y) 0.12
PE TTM —
TSR TTM (56.82%)
Mkt cap kr 173.5M
ROIC (26.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 2.89
11.07%
(97.92%)
Hold 9|6|11|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.07
0.07
0.07
0.08
34.72%
31.89%
23.86%
24.92%
Revenuekr M
10.85
10.72
10.62
11.02
10.83%
3.28%
1.39%
1.73%
Peers (US$17.54M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.702
(0.112)
(0.088)
EBIT/Intx
1.161
0.175
0.194
Own earn%
53.90
5.65
7.42
Sh yield%
39.09
50.15
50.00
Owners
Insiders/Inst%
7.95
66.21
Short interest%
5.30
SBC / revenue%
4.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
5–12
$1 testx
—
Incr. ROIC%
3